The manufacturer of the abortion pill mifepristone asked the Supreme Court to pause Friday’s decision by a federal appeals court that blocked mailing of the medication.
The request Saturday by Danco Laboratories LLC comes after the US Court of Appeals for the Fifth Circuit granted Louisiana’s request to temporarily halt Food and Drug Administration decisions that allowed mifepristone to be mailed into the state despite its abortion ban.
Friday’s order effectively blocks the FDA’s 2023 Risk Evaluation and Mitigation Strategy (REMS), which removed a requirement that mifepristone be dispensed in-person.
Danco on Friday asked the Fifth Circuit for an emergency ...